2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Leiomyoma
19
Myofibroma
4
Menorrhagia
4
Myoma
3
Infertility
3
Adenomyosis
2
Sexual Dysfunction, Physiological
1
Pregnancy Complications
1
Polyps
1
Pelvic Pain
1
Lower Urinary Tract Symptoms
1
Hemorrhage
1
Fibroma
1
Endometriosis
1
Dysmenorrhea
1
Blood Loss, Surgical
1
Agnosia
1
Interventions
Bupivacaine
11
Ketamine
9
Ropivacaine
8
Morphine
8
Analgesics, Opioid
8
Acetaminophen
8
Fentanyl
7
Dexmedetomidine
7
Lidocaine
6
Anesthesia, General
6
Saline Solution
5
Anesthesia, Local
5
Acupuncture Therapy
5
parecoxib
4
Tramadol
4
Surveys and Questionnaires
4
Sodium Chloride
4
Pregabalin
4
Ethanol
4
Analgesia, Epidural
4
Transcutaneous Electric Nerve Stimulation
3
Radiofrequency Ablation
3
Propofol
3
Oxycodone
3
Ketorolac
3
Control Groups
3
Anesthetics, Local
3
trimebutine 3-thiocarbamoylbenzenesulfonate
2
Therapeutics
2
Tea
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Agnosia
×
Uterine Myomectomy
×
Clear all
NCT01152112
2017-09-13
HOME
Hologic, Inc.
Phase NA
Completed
74 enrolled
5 charts